493 related articles for article (PubMed ID: 28334759)
1. Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.
Takayama K; Igai K; Hagihara Y; Hashimoto R; Hanawa M; Sakuma T; Tachibana M; Sakurai F; Yamamoto T; Mizuguchi H
Nucleic Acids Res; 2017 May; 45(9):5198-5207. PubMed ID: 28334759
[TBL] [Abstract][Full Text] [Related]
2. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
Zhang Y; Huang H; Zhang B; Lin S
Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
[TBL] [Abstract][Full Text] [Related]
3. Gene Editing With TALEN and CRISPR/Cas in Rice.
Bi H; Yang B
Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
[TBL] [Abstract][Full Text] [Related]
4. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
Cuculis L; Schroeder CM
Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
[TBL] [Abstract][Full Text] [Related]
5. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
6. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
[TBL] [Abstract][Full Text] [Related]
7. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
8. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
9. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
Merkert S; Martin U
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
[TBL] [Abstract][Full Text] [Related]
10. Genome editing: a robust technology for human stem cells.
Chandrasekaran AP; Song M; Ramakrishna S
Cell Mol Life Sci; 2017 Sep; 74(18):3335-3346. PubMed ID: 28405721
[TBL] [Abstract][Full Text] [Related]
11. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
Zhao G; Pu J; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
Kawahara A; Hisano Y; Ota S; Taimatsu K
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
[TBL] [Abstract][Full Text] [Related]
13. A highly efficient method for enriching TALEN or CRISPR/Cas9-edited mutant cells.
Yasuda H; Kim E; Reza AM; Kim JH
J Genet Genomics; 2016 Dec; 43(12):705-708. PubMed ID: 27916442
[No Abstract] [Full Text] [Related]
14. TALEN/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm.
Krentz NA; Nian C; Lynn FC
PLoS One; 2014; 9(12):e114275. PubMed ID: 25474420
[TBL] [Abstract][Full Text] [Related]
15. CRISPR Base Editing in Induced Pluripotent Stem Cells.
Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing During Development Using the CRISPR-Cas Technology.
Arzate-Mejía RG; Licona-Limón P; Recillas-Targa F
Methods Mol Biol; 2018; 1752():177-190. PubMed ID: 29564772
[TBL] [Abstract][Full Text] [Related]
17. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
18. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide-Mediated Genome Editing Provides Precision and Function to Engineered Nucleases and Antibiotics in Plants.
Sauer NJ; Narváez-Vásquez J; Mozoruk J; Miller RB; Warburg ZJ; Woodward MJ; Mihiret YA; Lincoln TA; Segami RE; Sanders SL; Walker KA; Beetham PR; Schöpke CR; Gocal GF
Plant Physiol; 2016 Apr; 170(4):1917-28. PubMed ID: 26864017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
